Symbol: |
BBS5
|
Description: |
Bardet-Biedl syndrome 5 [Source:HGNC Symbol;Acc:970]
|
Location: |
Chr2:170335688-170382432[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:260
Gene |
Compound |
Gen_sig |
Exp_pattern |
BBS5 |
11H-[1]Benzothiopyrano[2,3-e]imidazo[1,2-a]pyridine- 2-carboxamide, N-[3-(dimethylamino)propyl]-11-oxo- |
0.005 |
Up |
BBS5 |
1-[m-methyl anilino malonyl]-3-methyl-4-[4'-.beta.-sulphato ethyl sulphonyl phenyl azo]-5-pyrazolone |
0.044 |
Up |
BBS5 |
NSC 677036 |
0.047 |
Down |
BBS5 |
NSC 677187 |
0.045 |
Up |
BBS5 |
NSC 677194 |
0.04 |
Up |
BBS5 |
NSC 678039 |
0.037 |
Up |
BBS5 |
Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- |
0.004 |
Up |
BBS5 |
NSC 678058 |
0.019 |
Down |
BBS5 |
4H-1,3,6,2-Dioxazaphosphocinium, 4-hexadecyltetrahydro- 2,6,6-trimethyl-, bromide, 2-oxide |
0.046 |
Up |
BBS5 |
Benzoic acid, 2-[(4,6-dimethyl-1-oxo-2-indanylidene) methyl]-5-methyl-, methyl ester |
0.044 |
Up |
BBS5 |
Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- |
0.023 |
Up |
BBS5 |
Thymine, 1-[1,2-bis(ethoxycarbonyl)ethenyl]- |
0.022 |
Up |
BBS5 |
Adenine, 9-[1,2-bis(ethoxycarbonyl)ethenyl]-, trans- |
0.025 |
Up |
BBS5 |
Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-3-[(ethoxy-carbonyl)methyl]-, trans- |
0.013 |
Up |
BBS5 |
Z(OMe)-Gly-Ala-Phe-OBzl |
0.04 |
Up |
Expression pattern: Sensitivity / Resistance
Total:18 Current:9
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:76
Total:6 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:2
Gene |
Gen_transcript |
miRNA |
miR_location |
BBS5 |
ENST00000295240 |
hsa-mir-181a-3p |
Chr1:198828198-198828219[-] |
BBS5 |
ENST00000295240 |
hsa-mir-181c-3p |
Chr19:13985577-13985598[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|